Massive Bio

Massive Bio, an AI-powered platform connecting patients with clinical trials and CureMatch, a healthcare technology company leveraging Knowledge…

Massive Bio, a world-renowned provider of personalized oncology solutions, is set to showcase its groundbreaking GPT4 AI chatbots - AskFiona AI and …

Massive Bio, a leading artificial intelligence (AI) analytics company specializing in precision oncology, has been selected by the Precision Cancer…

Massive Bio, a leader in leveraging artificial intelligence and concierge services to empower cancer patients, is thrilled to announce a non-exclusive…

Massive Bio, a globally recognized leader in the oncology space, has proudly announced its appointment as a founding member of CancerX, a…

New York City-based Massive Bio, which uses artificial intelligence to match cancer patients to clinical trials, continues to grow outside the…

-Collaboration will leverage NeoGenomics’ large oncology diagnostic laboratory and Massive Bio’s proven-at-scale proprietary artificial…

Massive Bio, a leader in AI-powered cancer treatment, announced plans to launch a new AI-powered drug matching product in 2023 that will enable…

Fueled by increased demand from pharmaceutical companies and a $16.5 million new funding in 2022 to accelerate innovative cancer trial enrollment…

New partnership brings accurate trial recommendations to Azra AI’s national client base of medical systems and hospitals, including leading…